492 related articles for article (PubMed ID: 4205524)
21. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
Traeger A; Horváth T; Rechenbach C; Jávor T
Int J Clin Pharmacol Res; 1986; 6(3):235-9. PubMed ID: 3744626
[TBL] [Abstract][Full Text] [Related]
22. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
23. Proceedings: The influence of glucagon on regional blood flow in the rhesus monkey.
Branch RA; Nies AS; Shand DG
Br J Pharmacol; 1973 Sep; 49(1):149P. PubMed ID: 4207042
[No Abstract] [Full Text] [Related]
24. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
Shetty SN; Himes JA; Edds GT
Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
[No Abstract] [Full Text] [Related]
25. Liver blood flow. metabolic heat production and body temperature before, during and after phenobarbitone administration.
Ohnhaus EE; Tilvis R
Acta Hepatogastroenterol (Stuttg); 1976; 23(6):404-8. PubMed ID: 1007827
[TBL] [Abstract][Full Text] [Related]
26. Correlation between antipyrine clearance and cytochrome P-450 level after phenobarbital induction in rat.
Chang SL; Nelson SD; Levy RH
Drug Metab Dispos; 1984; 12(1):139-41. PubMed ID: 6141905
[No Abstract] [Full Text] [Related]
27. Medroxyprogesterone acetate does not induce antipyrine clearance and only weakly increases alpha 1-acid glycoprotein in beagle dogs.
Abramson FP; Moore CF; Hill MD
Res Commun Chem Pathol Pharmacol; 1986 Jul; 53(1):65-78. PubMed ID: 2944196
[TBL] [Abstract][Full Text] [Related]
28. A re-evaluation of intersubject variation in enzyme induction in man.
Branch RA; Shand DG
Clin Pharmacokinet; 1979; 4(2):104-10. PubMed ID: 455871
[TBL] [Abstract][Full Text] [Related]
29. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
30. Enzyme induction and beta-adrenergic receptor blocking drugs.
Branch RA; Herman RJ
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
32. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
[TBL] [Abstract][Full Text] [Related]
33. Impairment of drug elimination in patients with liver disease.
Narang AP; Datta DV; Mathur VS
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
[TBL] [Abstract][Full Text] [Related]
34. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
Fenyves D; Gariépy L; Villeneuve JP
Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
[TBL] [Abstract][Full Text] [Related]
35. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
Larousse C; Kergueris MF; Le Normand Y; Visset J
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
[TBL] [Abstract][Full Text] [Related]
36. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
McManus ME; Ilett KF
Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
[TBL] [Abstract][Full Text] [Related]
37. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
Hayes PC; Bouchier IA
Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
[TBL] [Abstract][Full Text] [Related]
38. The influence of propranolol and glucagon on the pharmacokinetics of antipyrine and sodium salicylate.
Orszulak-Michalak D; Kaszubski P
Pharmazie; 1987 Jun; 42(6):394-6. PubMed ID: 3671460
[TBL] [Abstract][Full Text] [Related]
39. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
Abramson FP; Lutz MP
Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
[TBL] [Abstract][Full Text] [Related]
40. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
